HomeNRBO • NASDAQ
add
Neurobo Pharmaceuticals Inc
Previous close
$2.35
Day range
$2.35 - $2.42
Year range
$2.08 - $6.75
Market cap
20.94M USD
Avg Volume
36.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.26M | 60.78% |
Net income | -5.65M | -48.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.25M | -60.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.68M | -16.09% |
Total assets | 22.15M | -16.19% |
Total liabilities | 9.19M | 88.57% |
Total equity | 12.95M | — |
Shares outstanding | 8.62M | — |
Price to book | 1.57 | — |
Return on assets | -61.49% | — |
Return on capital | -97.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.65M | -48.04% |
Cash from operations | -5.59M | -98.61% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -676.00K | — |
Net change in cash | -6.26M | -119.75% |
Free cash flow | -4.15M | -187.16% |
About
Founded
2014
Website
Employees
8
